MedTrace Logo

OptiScanner Versus Standard Blood Glucose Monitoring

NCT01720381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2014-06-24

No results posted yet for this study

Summary

The study is to demonstrate the accuracy of the OptiScanner in measuring blood glucose levels in critically ill patients when compared to a reference YSI 2300 STAT Plus and the Gem 3000, the reference standard for Erasme University Hospital.

Conditions

Sponsors & Collaborators

  • Erasme University Hospital

    collaborator OTHER

  • OptiScan Biomedical Corporation

    lead INDUSTRY

Principal Investigators

  • Jean-Charles Preiser, MD, PhD · Erasme University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01720381 on ClinicalTrials.gov